09:52 AM EST - Aurinia Pharmaceuticals Inc. : Has established its U.S. commercial center of operations in Rockville, Maryland. The new site will support Aurinia’s plans for growth as it prepares for the potential approval and launch of voclosporin for the treatment of lupus nephritis in 2021. Aurinia Pharmaceuticals Inc.
shares T.AUP are trading up $0.24 at $16.60.
